| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Chief Business Officer
2 companies
Sniecinski Megan serves as a Chief Business Officer at BCRX and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $11.1M at current prices.
The biggest single holding is PRAX (~$10.6M) as Chief Operating Officer.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 18, 2019 | BCRX Biocryst Pharmaceuticals Inc | Chief Business Officer | Buy | 45,000 | $1.45 | $65,250.00 | New |